ACTIVE INGREDIENT
Active Ingredient: Titanium Dioxide 10.44%, Zinc Oxide 1.44%
Active Ingredient: Titanium Dioxide 10.44%, Zinc Oxide 1.44%
Inactive Ingredients: Chamaecyparis Obtusa Water, Butylene Glycol, Cyclopentasiloxane, Phenyl Trimethicone, Hydrogenated Polydecene, Dipropylene Glycol, Cetyl PEG/PPG-10/1 Dimethicone, Cyclohexasiloxane, Niacinamide, Sodium Chloride, Butylene Glycol Dicaprylate/Dicaprate, Water, Bis-Diglyceryl Polyacyladipate-2, Iron Oxides (CI 77492), Polyglyceryl-4 Isostearate, Cetyl Ethylhexanoate, Methyl Hydrogenated Rosinate, Talc, Hexyl Laurate, Cetyl Dimethicone, Sorbitan Isostearate, Calcium Stearate, Dimethicone, Iron Oxides (CI 77491), Disteardimonium Hectorite, Phenoxyethanol, Glyceryl Polymethacrylate, Iron Oxides (CI 77499), Caprylyl Glycol, Glycerin, Propylene Glycol, Triethoxycaprylylsilane, Triethyl Citrate, Sorbitan Olivate, Fragrance, Hydrogenated Vegetable Oil, Alcohol, Hydrogen Dimethicone, Ethylhexylglycerin, 1,2-Hexanediol, Adenosine, Disodium EDTA, Sodium Hyaluronate, Bellis Perennis (Daisy) Flower Extract, Nelumbo Nucifera Flower Extract, Melaleuca Alternifolia (Tea Tree) Flower/Leaf/Stem Extract, Portulaca Oleracea Extract, Lilium Candidum Bulb Extract, Paeonia Lactiflora Root Extract, Centella Asiatica Extract
Purpose: Sunscreen
Warnings: 1. If any of the following symptoms appear on the area where the product was applied, stop using the product immediately and consult a specialist. A. Redness, swelling, itchiness, irritation or other abnormal symptoms B. Symptoms above appear after exposure to direct sunlight 2. DO NOT use the product on an area with wound, eczema, or dermatitis 3. Storage and handling. A. Make sure to close the lid after use B. Keep away from children and babies C. DO NOT store in a place with high or low temperature and direct sunlight
Directions & Usage: Apply a suitable amount to and spread evenly on your skin after all skin care.
Dosage & Administration: Take an adequate amount of this product.
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69894-290-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4669-f424-e053-dadaa90a57ce | dc0a6232-2821-40ff-ad0e-56306706a6e2 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69894-290-01 | HD WATERFUL BB | 50 mL in 1 CARTON | CREAM | 50 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Phenyl Trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69894-290 | 69894-290-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIM |
| Butylene Glycol | 3XUS85K0RA | IACT |
| Phenyl Trimethicone | DR0K5NOJ4R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 92d72973-416e-48a3-b3b6-b654ab0960bc | dc0a6232-2821-40ff-ad0e-56306706a6e2 | 2015-06-26 | Warnings | 92d72973-416e-48a3-b3b6-b654ab0960bc dc0a6232-2821-40ff-ad0e-56306706a6e2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.